Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Technique Allows Noninvasive Tracking, Imaging of Stem Cells in the Brain

By LabMedica International staff writers
Posted on 05 Apr 2011
A new technique using quantum dot technology generated through nanotechnology is a promising new tool for monitoring the effects of stem cell therapies for stroke and other types of brain damage. More...


The study's findings were published in the April 2011 issue of the journal Neurosurgery, the journal of the Congress of Neurological Surgeons. The researchers reported the successful use of near-infrared fluorescence labeling to track the behavior of injected stem cells in brain-injured rats. "The results open up new opportunities to develop noninvasive near-infrared fluorescence imaging...to track bone marrow stem cells transplanted into the human brain,” wrote Dr. Taku Sugiyama and colleagues of Hokkaido University Graduate School of Medicine (Sapporo, Japan).

The researchers utilized bone marrow stem cells to treat induced brain injuries, similar to stroke, in rats. Before injection, the stem cells were labeled with quantum dots, a biocompatible, fluorescent semiconductor created using nanotechnology.

Other fluorescence techniques used to label stem cells have an important limitation their comparatively short wavelengths do not easily penetrate through bone and skin. The quantum dots emit near infrared light, with much longer wavelengths that can easily penetrate tissues. This allowed the researchers to monitor the behavior of stem cells within the brain after transplantation using a computer-assisted, three-dimensional (3D) imaging system.

Using this technology, Dr. Sugiyama and colleagues were able to detect near-infrared fluorescence from the stem cells as they moved to and incorporated themselves into the area around the injured area of the brain. Reflecting the stem cells' behavior, the fluorescence increased gradually, peaking at four weeks after injection. The fluorescence remained detectable for up to eight weeks. The results were validated by direct examination of the brains.

Stem cell transplantation is a potentially beneficial treatment for stroke and other central nervous system disorders. The use of stem cells developed from the patient's own bone marrow is a particularly promising approach. For example, a study in the March 2011 issue of the journal Neurosurgery reported that bone marrow stem cell transplantation was a "logistically feasible and safe” approach to treatment of severe traumatic brain injury in children.

However, some sort of imaging system is needed to track the activity of stem cells as they travel to the injured area and develop into new brain cells. "Such techniques would be crucial to validate the therapeutic benefits of bone marrow stem cell transplantation for central nervous system disorders,” Dr. Sugiyama and coauthors wrote in their article.

Near-infrared fluorescence labeling using quantum dots appears to provide a noninvasive technique for monitoring the effects of stem cell transplantation in the rat brain. Additional studies will be needed to see if similar techniques can be developed and used in humans, according to the researchers. If so, this technology would be an important part of experimental stem cell therapies to enhance functional recovery of the brain after stroke or other types of injury.

Related Links:

Hokkaido University Graduate School of Medicine



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.